While clinical remote monitoring, artificial intelligence (AI) and other elements enabling greater adoption of decentralized clinical trials (DCTs) were part of the clinical research conversation before COVID-19, their adoption skyrocketed as quarantine took hold. Get in-the-moment insight on how these changes will shape the future of clinical trials from Raconteur, including comments from our own Graham Belgrave, Senior Vice President, Head of Global Medical & Regulatory Affairs and Managing Director, Europe.

Download Article

Interested in more of Graham’s perspectives on the pharmaceutical industry? Check out pharmaphorum’s 12 Questions With… spotlight for additional wisdom from this in-house expert.

Exceptional Strategies for Decentralized Trials

Don’t be intimidated by the increased shift to decentralized and hybrid clinical trials. Advanced Clinical supports partners around the world with customized, end-to-end solutions based on four key considerations:

  • Trial dependent flexibility
  • Global feasibility
  • Investigative site engagement
  • Patient and caregiver focus

See how our dedicated services help you succeed on our Hybrid & Decentralized Trials page.

Find even more insight in our Optimised Clinical Research Through Decentralised Trials article.